Product nameRecombinant Human Myelin Basic Protein
See all Myelin Basic Protein proteins and peptides
Protein lengthFull length protein
Amino Acid Sequence
SequenceMSPILGYWKI KGLVQPTRLL LEYLEEKYEE HLYERDEGDK WRNKKFELGL EFPNLPYYIDGDVKLTQSMA IIRYIADKHN MLGGCPKERA EISMLEGAVL DIRYGVSRIA YSKDFETLKVDFLSKLPEML KMFEDRLCHK TYLNGDHVTH PDFMLYDALD VVLYMDPMCL DAFPKLVCFKKRIEAIPQID KYLKSSKYIA WPLQGWQATF GGGDHPPKSD LVPRGSPEFM ASQKRPSQRHGSKYLATAST MDHARHGFLP RHRDTGILDS IGRFFGGDRG APKRGSGKDS HHPARTAHYGSLPQKSHGRT QDENPVVHFF KNIVTPRTPP PSQGKGRGLS LSRFSWGAEG QRPGFGYGGRASDYKSAHKG FKGVDAQGTL SKIFKLGGRD SRSGSPMARR
TagsGST tag N-Terminus
Additional sequence informationGST-tag ID: P08515 (226aa), Thrombin site: 221-226aa, 3-AA Linker: 227-229aa, MBP protein: 230-400aa
- Recombinant human Aurora B protein (ab51435)
- Recombinant human CaMKK protein (ab55692)
- Recombinant human MAP3K8 protein (ab55700)
- Recombinant human MAP4K6 protein (ab55712)
- Recombinant human Raf1 (mutated Y341 E + Y341 E) protein (ab55721)
- Recombinant human MEK2 protein (ab60013)
- Recombinant human ITK / EMT protein (ab60300)
- Recombinant human ASK1 protein (ab60325)
- Recombinant human MST4 protein (ab60341)
- Recombinant human TXK protein (ab60900)
- Recombinant mouse PAK3 protein (ab61414)
- Recombinant human TGF beta Receptor II protein (ab63173)
- Recombinant human IPL-1/STK13/Aurora C protein (ab63177)
Our Abpromise guarantee covers the use of ab43614 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ab43614 (Human Myelin Basic Protein full length protein) can be utilized as a substrate for the following active protein Kinases:
ab55712 (Active human MAP4K6 protein fragment)
ab60300 (Active ITK protein fragment)
ab60325 (Active human ASK1 protein fragment)
ab60341 (Active human MST4 full length protein)
ab60900 (Active TXK protein fragment)
ab61414 (Active mouse PAK3 full length protein)
ab63173 (Active TGF beta Receptor II protein fragment)
ab63177 (Active human IPL-1/STK13/Aurora C full length protein)
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.
Constituents: 0.0038% EGTA, 0.00174% PMSF, 0.00385% DTT, 0.79% Tris HCl, 0.00292% EDTA, 25% Glycerol, 0.87% Sodium chloride
- Golli MBP
- Golli MBP; myelin basic protein
FunctionThe classic group of MBP isoforms (isoform 4-isoform 14) are with PLP the most abundant protein components of the myelin membrane in the CNS. They have a role in both its formation and stabilization. The smaller isoforms might have an important role in remyelination of denuded axons in multiple sclerosis. The non-classic group of MBP isoforms (isoform 1-isoform 3/Golli-MBPs) may preferentially have a role in the early developing brain long before myelination, maybe as components of transcriptional complexes, and may also be involved in signaling pathways in T-cells and neural cells. Differential splicing events combined with optional post-translational modifications give a wide spectrum of isomers, with each of them potentially having a specialized function. Induces T-cell proliferation.
Tissue specificityMBP isoforms are found in both the central and the peripheral nervous system, whereas Golli-MBP isoforms are expressed in fetal thymus, spleen and spinal cord, as well as in cell lines derived from the immune system.
Involvement in diseaseNote=The reduction in the surface charge of citrullinated and/or methylated MBP could result in a weakened attachment to the myelin membrane. This mechanism could be operative in demyelinating diseases such as chronical multiple sclerosis (MS), and fulminating MS (Marburg disease).
Sequence similaritiesBelongs to the myelin basic protein family.
Developmental stageExpression begins abruptly in 14-16 week old fetuses. Even smaller isoforms seem to be produced during embryogenesis; some of these persisting in the adult. Isoform 4 expression is more evident at 16 weeks and its relative proportion declines thereafter.
modificationsSeveral charge isomers of MBP; C1 (the most cationic, least modified, and most abundant form), C2, C3, C4, C5, C6, C7, C8-A and C8-B (the least cationic form); are produced as a result of optional PTM, such as phosphorylation, deamidation of glutamine or asparagine, arginine citrullination and methylation. C8-A and C8-B contain each two mass isoforms termed C8-A(H), C8-A(L), C8-B(H) and C8-B(L), (H) standing for higher and (L) for lower molecular weight. C3, C4 and C5 are phosphorylated. The ratio of methylated arginine residues decreases during aging, making the protein more cationic.
The N-terminal alanine is acetylated (isoform 3, isoform 4, isoform 5 and isoform 6).
Arg-241 was found to be 6% monomethylated and 60% symmetrically dimethylated.
Cellular localizationMyelin membrane. Cytoplasmic side of myelin.
- Information by UniProt
ab43614 has not yet been referenced specifically in any publications.